Sovaldi treatment- Archive
CAIRO – 30 April 2017: The Ministry of Health’s National Committee for the Control of Viral Hepatitis (NCCVH) is targeting the treatment of 400,000 Hepatitis C patients during 2017, head of NCCVH Waheed Doos said.
Doos told Egypt Today that the treatment protocols, related to Hepatitis C, are being upgraded in accordance with the best treatments available globally.
He added that new medications for Hepatitis C will be provided during the coming period.
Egypt has successfully treated Hepatitis C patients with a locally-manufactured version of an imported Hepatitis C medicine called Solvadi, said Sherif Rashed a member in the Pharmaceutical Manufacturers Association.
He said that the Egyptian versions of Harvoni and Magicbuvir plus medications, with European manufacturing criteria, will be released in Egypt very soon.
According to the World Health Organisation (WHO), Egypt is ranked as the nation with the highest rate of Hepatitis C infection.
Hepatitis C is transmitted through unexamined blood transfusions, multiple uses of syringes, reusing of medical equipment, poor sterilization and sexual intercourse, according to the WHO.